Compound, composition and uses thereof

Abstract

The disclosure herein provides the compounds of Formulas 1 and its pharmaceutical acceptable salts, as well as polymorphs, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administration, transdermal administration, and/or injection. Such compositions may be used for the treatment of metabolic conditions, cystinosis, non-alcoholic Steatohepatitis, hypertriglyceridemia, and/or neurodegenerative disorders, and/or their associated complications.

What is claimed is: 
     
         1 . A method of treating at least one of a cardiovascular disease, a hepatic disease, a genetic disorder, and a metabolic disorder comprising:
 administering the compound of Formula 1 to a patient suffering from at least one of a cardiovascular disease, a hepatic disease, a genetic disorder, and a metabolic disorder.   
       
         
           
           
               
               
           
         
       
     
     
         2 . The method of  claim 1 , further comprising administering the compound of comprising Formula 1 through at least one of a non-invasive peroral, a topical ointment, an enteral, a gel solution, a syrup, a lotion, a healing pad, a transmucosal delivery, a targeted delivery, a sustained release delivery, a delayed release delivery, a pulsed release delivery, a patch, and a parenteral delivery. 
     
     
         3 . The method of  claim 2 , wherein the method treats at least one of a hypertriglyceridemia disorder, a stroke, an atrial fibrillation, a coronary heart disease, a non-alcoholic Steatohepatitis, cystinosis, nephropathic cystinosis, and Huntington's disease.